Supplemental Oxygen in Pulmonary Embolism (SO-PE)
This study is looking at how giving extra oxygen, called supplemental oxygen, helps adults who have a sudden blood clot in their lungs (acute pulmonary embolism or PE). Researchers want to see if breathing supplemental oxygen, delivered through a non-rebreather mask, can reduce the pressure in the lung arteries and improve how the right side of the heart works. You might be able to join if you are an adult (18 or older) with a recently confirmed PE, new or worsening symptoms, and your doctor has confirmed your heart's right side isn't working as well as it should, even if your oxygen levels are currently good. The main goal is to measure the pressure in your lung arteries at 30, 60, and 90 minutes after receiving either supplemental oxygen or regular room air. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study planning to enroll 80 adult participants. It is a randomized, crossover trial where participants will receive both supplemental oxygen and room air at different times.
- What's involved
- You would receive supplemental oxygen or room air for periods of 30, 60, and 90 minutes, and then for 180 minutes. After each treatment change and at 180 minutes, you would have echocardiograms and blood draws.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary measurements are taken at 30, 60, and 90 minutes after treatment, and then at 180 minutes.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
At a glance
Conditions
NCT05891886
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Massachusetts General Hospital
Boston, Massachusettsstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Christopher Kabrhel, MD, MPH · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Pulmonary artery systolic pressure (PASP)30 minutes after study treatment (supplemental oxygen) or placebo (room air)
PASP is measured on bedside echocardiogram
- Pulmonary artery systolic pressure (PASP)60 minutes after study treatment (supplemental oxygen) or placebo (room air)
PASP is measured on bedside echocardiogram
- Pulmonary artery systolic pressure (PASP)90 minutes after study treatment (supplemental oxygen) or placebo (room air)
PASP is measured on bedside echocardiogram
- Pulmonary artery systolic pressure (PASP)180 minutes after study treatment (supplemental oxygen) or placebo (room air)
PASP is measured on bedside echocardiogram